Allosteric regulation of binding and function at GPCRS

被引:5
作者
Birdsall, NJM
Browning, C
Hern, J
Lazareno, S
机构
[1] Natl Inst Med Res, Div Phys Biochem, London NW7 1AA, England
[2] MRC Technol, London NW7, England
关键词
D O I
10.1007/s00044-004-0009-7
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Allosteric ligands, in contrast to competitive agonists and antagonists, act to tune up (or down) receptor function whilst maintaining the important temporal aspects of intercellular receptor signalling in the nervous system. In addition, some allosteric ligands exhibit 'absolute subtype selectivity'; action at one subtype but no action at any concentration at other subtypes. Some allosteric ligands also have pharmacological actions in the absence of orthosteric ligands and can act as inverse agonists or agonists in their own right by modulating constitutive activity. Examples of the novel pharmacological aspects and mechanisms of the actions of a number of allosteric ligands on muscarinic and adenosine A(1) receptors are described.
引用
收藏
页码:52 / 62
页数:11
相关论文
共 46 条
[1]  
Birdsall NJM, 1999, MOL PHARMACOL, V55, P778
[2]  
Birdsall NJM, 1996, PROG BRAIN RES, V109, P147
[3]  
BIRDSALL NJM, 1981, BRIT J PHARMACOL, P142
[4]  
Browning C, 2000, BRIT J PHARMACOL, V131
[5]  
BRUNS RF, 1990, MOL PHARMACOL, V38, P939
[6]  
Caulfield MP, 1998, PHARMACOL REV, V50, P279
[7]   G protein-coupled receptor allosterism and complexing [J].
Christopoulos, A ;
Kenakin, T .
PHARMACOLOGICAL REVIEWS, 2002, 54 (02) :323-374
[8]   INHIBITORY EFFECT OF GALLAMINE ON MUSCARINIC RECEPTORS [J].
CLARK, AL ;
MITCHELSON, F .
BRITISH JOURNAL OF PHARMACOLOGY, 1976, 58 (03) :323-331
[9]  
Cohen Fiona, 1994, British Journal of Pharmacology, V113, p51P
[10]  
DELEAN A, 1980, J BIOL CHEM, V255, P7108